Severity
Not classified by agency
CPSC recall · Reported April 25, 2019
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children …
TriDerma, of Corona, Calif. recalled This recall involves TriDerma Pain Relief Cream with 4% Lidocaine in a jar and tube. The ….
TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Require… was recalled by TriDerma, of Corona, Calif. in April 25, 2019. Reason: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving c…. Remedy: Consumers should immediately store the topical anesthetic in a safe location, out of reac…. Verify recall #19742 with the CPSC before acting.
The recall
TriDerma, of Corona, Calif. issued this CPSC recall-The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving c….
Sourced from official CPSC enforcement records. Verify recall #19742 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This CPSC action (record #19742) was formally reported on April 25, 2019. The CPSC does not publish a hazard classification for its recalls, so this record carries no agency severity grade, with a current status of Active. TriDerma, of Corona, Calif. is listed as the recalling firm. Federal records list the affected scope as About 410.
The documented reason for this recall is: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest i… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all know… - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls, 6 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,772 children & baby products recalls on record
Severity
Not classified by agency
Affected scope
About 410
Related Recalls
6
6 from same agency
This recall involves TriDerma Pain Relief Cream with 4% Lidocaine in a jar and tube. The 4 ounce jar is white with a lime green and pink printed label and has a white dome cap. The 2.2 ounce tube is white with a lime green and pink printed label. The lot numbers and expiration dates of the affected products can be found on the bottom of the jar and on the front of the crimped end of the tube. "TriDerma Pain Relief Cream" is printed on the jar and tube. Lot Number Expiration Date 21088 04/2021 20189 04/2021 0738F02A 06/2021 0738F04A 06/2021 0738F04B 06/2021 0738F04C 06/2021 0739A22A 01/2022 0739A22B 01/2022 0739A23A 01/2022
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Not classified by agency |
| Status | Active |
| Recall number | 19742 |
| Date reported | April 25, 2019 |
| Date initiated | April 25, 2019 |
| Recalling firm | TriDerma, of Corona, Calif. |
| Affected scope | About 410 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a…
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.
Same archive severity grade, closest by report date among other firms and states.
Same product category, closest by report date among other firms and states (deduped against the severity set).
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Showing 5 of 4006 other recalls in this category.
EEMB USA, doing business as A2batt, Inc., of Redlands, California · 2026-08-06
Shenzhen Okabesini Technology Co., Ltd., dba Okabesini-us, of China · 2026-08-06
· 2026-08-06
Changsha Yuelu District Ruiwu E-Commerce Co., Ltd., dba WURUI.BABY, of China · 2026-08-06
· 2026-07-30
Compare this recall with A2batt Recalls EEMB Lithium Coin Battery Chargers Due to Ri… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported April 25, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.